khtm table contents united states securities and exchange commission washington dc form annual report pursuant section dof securities exchange act for fiscal year ended december or transition report pursuant section dof securities exchange act for transition period commission file number cvs caremark corporation exact name registrant specified charter delaware state jurisdiction incorporation organization irs employer identification no one cvs drive woonsocket rhode island address principal executive offices zip code registrants telephone number including area code securities registered pursuant sectionbof exchange act common stock par value per share new york stock exchange title class name exchange registered securities registered pursuant sectiongof exchange act none indicate check mark registrant well known seasoned issuer defined rule securities actyes no indicate check mark registrant required file reports pursuant section sectiondof actyes no indicate check mark whether registrant filed reports required filed section dof securities exchange act preceding months shorter period registrant required file reports subject filing requirements past daysyes no indicate check mark whether registrant submitted electronically posted corporate website every interactive data file required submitted posted pursuant rule regulation preceding months shorter period registrant required submit post filesyes no indicate check mark disclosure delinquent filers pursuant item regulation contained herein contained best registrants knowledge definitive proxy information statements incorporated reference partiii form amendment form indicate check mark whether registrant large accelerated filer accelerated filer non accelerated filer smaller reporting company see definition large accelerated filer accelerated filer smaller reporting company ruleb exchange act largeacceleratedfiler accelerated filer non accelerated filer smaller reporting company do check smaller reporting company indicate check mark whether registrant shell company defined ruleb actyes no the aggregate market value registrants common stock held non affiliates approximately june based closing price common stock new york stock exchange for purposes calculation executive officers directors deemed affiliates registrant as february registrant shares common stock issued outstanding documents incorporated by reference filings made companies securities exchange commission sometimes incorporate information reference this means company referring information previously filed filed sec information considered part filing reading the following materials incorporated reference form portions annual report stockholders fiscal year ended december incorporated reference response items partii information contained proxy statement annual meeting stockholders incorporated reference response items ofpart iii table contents table of contents page parti item business itema risk factors itemb unresolved staff comments item properties item legal proceedings item submission matters vote security holders executive officers registrant partii item market registrants common equity related stockholder matters issuer purchases equity securities item selected financial data item managements discussion analysis financial condition results operations itema quantitative qualitative disclosures about market risk item financial statements supplementary data item changes disagreements accountants accounting financial disclosure itema controls procedures itemb other information partiii item directors executive officers corporate governance item executive compensation item security ownership certain beneficial owners management related stockholder matters item certain relationships related transactions director independence item principal accountant fees services partiv item exhibits financial statement schedules signatures table contents parti item business overview cvs caremark corporation cvs caremark company us together subsidiaries largest pharmacy health care provider united states integrated offerings across entire spectrum pharmacy care cvs caremark uniquely positioned deliver significant benefits health plan sponsors effective cost management solutions innovative programs engage plan members promote healthier cost effective behaviors our integrated pharmacy services model enhances ability offer plan members consumers expanded choice greater access personalized services help path better health we effectively manage pharmaceutical costs improve health care outcomes pharmacy benefit management pbm mail order specialty pharmacy division cvs caremark pharmacy services approximately cvspharmacy retail stores retail based health clinic subsidiary minuteclinic online retail pharmacy cvscom we currently three reportable business segments pharmacy services retail pharmacy corporate pharmacy services segment the pharmacy services segment provides full range pbm services described fully clients consisting primarily employers insurance companies unions government employee groups managed care organizations sponsors health benefit plans individuals throughout united states in addition silverscript insurance company silverscript accendo insurance company accendo pennsylvania life insurance company pennsylvania life subsidiaries national provider drug benefits eligible beneficiaries federal governments medicare partd program currently pharmacy services business operates cvs caremark pharmacy services caremark cvs caremark careplus cvspharmacy careplus rxamerica accordant names as december pharmacy services segment operated retail specialty pharmacy stores specialty mail order pharmacies four mail service pharmacies located states district columbia puerto rico pharmacy services business strategy our business strategy centers providing innovative pharmaceutical solutions quality client service order enhance clinical outcomes clients health benefit plan members assisting clients plan members better managingoverall health care costswe produce superior results clients plan membersby leveragingour expertise core pbm services includingplan design administration formulary management discounted drug purchase arrangements medicare partd services mail order specialty pharmacy services retail pharmacy network management services prescription management systems clinical services disease management services pharmacogenomics in addition fully integrated pharmacy services company able offer clients plan members variety programs plan designs benefit integrated information systems ability pharmacists nurse practitioners physician assistants interact personally many plan members shop stores every daythrough multiple member touch points retail stores mail order specialty pharmacies retail clinics call centers proprietary websites seek engage plan members behaviors lower cost improve health care outcomesexamples programs services include maintenance choice program eligible client plan members elect fill maintenance prescriptions retail pharmacy stores price mail order pharmacy advisor program uses consumer engagement engine tm technology facilitate face face telephone counseling pharmacists help participating plan members certain chronic diseases diabetes cardiovascular conditions identify gaps care adhere prescribed medications manage health conditions compliance persistency programs designed ensure patients take medications proper manner enhanced disease management programs targeted managing chronic disease states extracare health card program offers discounts eligible plan members certain counter health care products sold cvspharmacy storesin addition working clients idecrease unnecessary expensive emergency room visits encouraging plan members use minuteclinic locations everyday common ailments iicreate pilot programs offer convenient unique services available minuteclinicsuch injection training specialty pharmacy services table contents pbm services our pbm services described fully plan design administration our clients sponsor pharmacy benefit plans facilitate ability eligible members plans receive prescribed medications we assist clients designing pharmacy benefit plans minimize costs client prioritizing welfare safety clients members we also administer benefit plans clients assist monitoring effectiveness plans frequent informal communications well formal annual client review we make recommendations clients encouraging design benefit plans promoting use lowest cost clinically appropriate drug we believe help clients control costs recommending plan designs encourage use generic equivalents brand name drugs equivalents available our clients also option plan design lower pharmacy benefit plan costs setting different member payment levels different products drug lists formulary management we utilize independent panel doctors pharmacists medical experts referred pharmacy therapeutics committee select drugs meet highest standards safety efficacy inclusion drug lists our drug lists provide recommended products numerous drug classes ensure member access clinically appropriate alternatives clients pharmacy benefit plan to improve clinical outcomes members clients conduct ongoing independent reviews drugs including limited appearing drug lists generic equivalent products well clinical programs many clients choose adopt drug lists part plan design discounted drug purchase arrangements we negotiate pharmaceutical companies obtain discounted acquisition costs many products drug lists negotiated discounts enable us offer reduced costs clients choose adopt drug lists the discounted drug purchase arrangements negotiate typically provide volume discounts andor payment pharmaceutical companies retroactive discounts rebates established list prices for certain products purchased pharmacies receive discounts time purchase andor discounts prompt payment invoices we also receive various purchase discounts wholesale contracts may include retroactive discounts rebates exceed contractually defined purchase volumes we record discounts regardless form reduction cost revenues medicare partd services we participate administration drug benefit added medicare program partd medicare prescription drugimprovement modernization act mma medicare partd provision pbm services health plan clients clients qualified medicare partd prescription drug plans pdp we also participate iby offering medicare partd pharmacy benefits subsidiaries silverscript accendo pennsylvania life approved centers medicare medicaid services cms pdps iiby assisting employer union health plan clients qualify retiree drug subsidy available medicare partd collecting submitting eligibility andor drug cost data cms order obtain subsidy on april company acquired medicare prescription drug business universal american corp uam medicare partd business approximately billion mail order pharmacy as december operated four large automated mail service pharmacies united states plan members prescribers submit prescriptions refill requests primarily maintenance medications pharmacies via mail telephone fax prescribing internet we also operate network smaller mail service specialty pharmacies described our staff pharmacists review mail service prescriptions refill requests assistance prescription management systems this review may involve communications prescriber prescribers approval result generic substitution therapeutic interchange actions designed reduce cost improve quality treatment specialty pharmacy our specialty pharmacies support individuals require complex expensive drug therapies as december specialty pharmacies comprised specialty mail order pharmacies located throughout united states used delivery advanced medications individuals chronic genetic diseases disorders substantially pharmacies accredited joint commission independent profit organization accredits certifies health care organizations programs united states as december company operated network retail specialty pharmacy stores operate careplus cvspharmacy name these stores average square feet size sell prescription drugs limited assortment front store items alternative medications homeopathic remedies vitamins table contents retail pharmacy network management we maintain national network approximately retail pharmacies including cvspharmacy stores when customer fills prescription retail pharmacy pharmacy sends prescription data electronically us point sale this data interfaces proprietary prescription management systems verify relevant plan member data eligibility also performing drug utilization review evaluate clinical appropriateness safety confirming pharmacy receive payment prescription prescription management systems we dispense prescription drugs directly one mail service specialty pharmacies network retail pharmacies all prescriptions whether filled one mail service pharmacies pharmacy retail network analyzed processed documented proprietary prescription management systems these systems assist staff network pharmacists processing prescriptions automating review various items including limited plan eligibility early refills duplicate dispensing appropriateness dosage drug interactions allergies utilization potential fraud clinical services we offer multiple clinical programs services help clients manage overall pharmacy health care costs clinically appropriate manner our programs primarily designed promote safety target inappropriate utilization non adherence medication may result adverse medical events negatively impact members health clients pharmacy medical spend in regard offer various utilization management medication management quality assurance adherence counseling programs complement clients plan design clinical strategies disease management programs our clinical services utilize advanced protocols offer clients convenience working health care providers third parties our accordant health management programs include integrated rare disease management programs cover diseases rheumatoid arthritis parkinsons disease seizure disorders multiple sclerosis the majority integrated programs accredited national committee quality assurance ncqa private profit organization evaluates accredits certifies wide range health care organizations in addition entered strategic alliance alere llc management common disease management program offerings cover chronic diseases asthma diabetes congestive heart failure coronary artery disease pharmacogenomic services we majority interest generation healthinc genetic benefit management company allow us expand offering pharmacogenomic clinical testing services pbm clients pharmacogenomics study genetic makeup affects individuals response drug therapies through genetic testing doctors able evaluate patients genetic makeup determine effectiveness specific drugs drug dosages drug combinations through relationship expect use genetic testing apply greater precision client prescription management goal improving individual health outcomes reducing overall medical costs we began offer services certain drug therapies limited pilot basis clients rolled services additional clients pharmacy services information systems we currently operate multiple information systems platforms support pharmacy services segment these information systems incorporate architecture centralizes data generated filling mail service prescriptions adjudicating retail pharmacy claims fulfilling pbm clients service contracts as part streamlining initiative consolidating adjudication platforms one destination platform enhanced capabilities pharmacy services clients our clients primarily sponsors health benefit plans employers unions government employee groups insurance companies managed care organizations individuals located throughout united states we provide pharmaceuticals eligible members benefit plans maintained clients utilize information systems among things perform safety checks drug interaction screening generic substitution we generate substantially pharmacy services segment net revenue dispensing prescription drugs eligible members benefit plans maintained clients no single pbm client accounted total consolidated revenues our client agreements subject renegotiation terms see risk factors efforts reduce reimbursement levels alter health care financing practices risks declining gross margins pbm industry during year ended december pbm filled managed approximately million prescriptions seasonality the majority pharmacy services segment revenues seasonal nature table contents pharmacy services competition we believe primary competitive factors industry include ithe ability negotiate favorable discounts drug manufacturers iithe ability negotiate favorable discounts access retail pharmacy networks iiiresponsiveness clients needs ivthe ability identify apply effective cost management programs utilizing clinical strategies vthe ability develop utilize preferred drug lists vithe ability market pbm products services viithe commitment provide flexible clinically oriented services clients viiithe quality scope costs products services offered clients members the pharmacy services segment competes number large national pbm companies including express scriptsinc esi medco health solutionsinc medco well many smaller local regional pbmsin esi medco announced plans merge businesses subject various closing conditions regulatory approvals it remains unclear whether merger completed we also compete several large health insurersmanaged care plans eg united healthcare cigna pbm capabilities well several national regional companies provide services similar retail pharmacy segment as december retail pharmacy segment included retail drugstores operated pharmacy online retail pharmacy website cvscom onsite pharmacy stores retail health care clinics the retail drugstores located states puerto rico district columbia operating primarily cvspharmacy name we currently operate top us drugstore markets hold number one number two market share markets cvspharmacy stores sell prescription drugs wide assortment general merchandise refer front store products existing retail stores range size approximately square feet although new stores range size approximately square feet typically include drive thru pharmacy during filled approximately million retail prescriptions approximately us retail pharmacy market as december operated retail health care clinics states district columbia minuteclinic name located within cvspharmacy stores retail pharmacy business strategy our integrated pharmacy services model enhanced ability retail pharmacy stores expand customer access care helping lower overall health care costs improve health outcomes in regard role retail pharmacist shifting primarily dispensing prescriptions also providing services including flu vaccinations well face face patient counseling respect adherence drug therapies closing gaps care cost effective drug therapies in addition seek easiest pharmacy retailer customers use we believe ease use means convenience time starved customer as strategy conveniently located stores many open extended hours hours per day offer drive pharmacy services practicable we also provide broad assortment quality merchandise competitive prices using retail format emphasizes service innovation convenience easy access clean well lit well stocked one keys strategy technology allows us focus constantly improving service exploring ways provide personalized product offerings services we believe continuing first market new unique products services using innovative marketing adjusting mix merchandise match customers needs preferences important ability continue improve customer satisfaction retail pharmacy products services typical cvspharmacy store sells prescription drugs wide assortment high quality nationally advertised brand name private label merchandise front store categories include counter drugs beauty products cosmetics film photo finishing services seasonal merchandise greeting cards convenience foods we purchase merchandise numerous manufacturers distributors we believe competitive sources readily available substantially products carry loss one supplier would material effect business table contents consolidated net revenues major product group follows percentageofnetrevenues prescription drugs over counter personal care beautycosmetics general merchandise percentages estimates based store point sale data pharmacy pharmacy revenues represented two thirds retail pharmacy revenues we believe pharmacy operations continue represent critical part business due favorable industry trends eg aging american population consuming greater number prescription drugs pharmaceuticals used often first line defense managing illness impact health care reform proliferation new pharmaceutical products medicare partd ongoing program purchasing customer lists independent pharmacies we believe pharmacy business benefits investment people technology given nature prescriptions people want prescriptions filled accurately ready promised professional pharmacists using latest tools technology consumers need medication management programs better information help get health care dollars to assist customers needs introduced integrated pharmacy health care services provide earlier easier effective approach engaging behaviors help lower costs improve health save lives examples include patient care initiative enhanced medication adherence program customer savings initiative educates customers cost savings opportunities maintenance choice flexible fulfillment option affords eligible pbm plan members convenient choice filling day supply maintenance medications cvspharmacy store obtaining mail order either case cost mail typically lower plan member payor pharmacy advisor program uses consumer engagement engine technology facilitate pharmacist counseling face face telephone help participating plan members certain chronic diseases diabetes cardiovascular conditions identify gaps care adhere prescribed medications manage health conditions extracare health card program further evidencing belief importance pharmacy service continuing investment technology drug utilization review system checks harmful interactions prescription drugs counter products vitamins herbal remedies pharmacy fulfillment system rx connect touch tone telephone reorder system rapid refill tm online business cvscom front store front store revenues benefited strategy first market new unique products services using innovative marketing adjusting mix merchandise match customers needs preferences key component front store strategy extracare card program helping us continue build loyal customer base the extracare program one largest successful retail loyalty programs united states in addition extracare program allows us balance marketing efforts reward best customers providing automatic sale prices customized coupons extrabucks rewards benefits another component front store strategy unique product offerings include full range high quality cvspharmacy proprietary brand products available cvspharmacy stores we currently carry cvspharmacy proprietary brand products accounted approximately front store revenues furthermore tailoring certain groups stores better meet needs customers urban cluster stores table contents minuteclinic as december operated minuteclinic locations states district columbia located cvspharmacy storesminuteclinics staffed nurse practitioners physician assistants utilize nationally recognized protocols diagnose treat minor health conditions perform health screenings monitor chronic conditions deliver vaccinationsmany locations also begun treating variety chronic conditionsinsurers value minuteclinic provides convenient high quality cost effective care many cases offering attractive alternative far expensive emergency roomas result visits paid employers health insurers third parties accounted approximately minuteclinics total revenues we anticipate opening approximately new clinics cvspharmacy stores minuteclinic collaborating pharmacy services segment help meet needs cvs caremark plan members offering programs improve member health lower costs onsite pharmacies we also operate limited number small pharmacies located client sites careplus cvspharmacy careplus tm cvspharmacy name provide certain health plan members customers convenient alternative filling prescriptions retail pharmacy store development the addition new stores played continue play major role continued growth success our store development program focuses three areas entering new markets adding stores within existing markets relocating stores convenient freestanding sites during opened new retail pharmacy stores relocated stores closed stores during last five years opened new relocated stores acquired approximately stores during expect open new relocated stores close approximately stores we believe continuing grow store base locating stores desirable geographic markets essential components compete effectively current managed care environment as result believe store development program integral part ability maintain leadership position retail drugstore industry retail pharmacy information systems we continued invest information systems enable us deliver high level customer service lowering costs increasing operating efficiency in completed rollout rx connect reengineered way pharmacists communicate fill prescriptions our consumer engagement engine technology enables us message pharmacists point care facilitates face face counseling regarding patient health safety matters including adherence issues gaps care management certain chronic health conditions we one first industry introduce drug utilization review technology checks harmful interactions prescription drugs counter products vitamins herbal remedies we also one first industry install chain wide automatic prescription refill system cvs rapid refill enables customers order prescription refills hours day using touch tone telephone we continue enhance visible improvement profits execution results viper system transaction monitoring application designed mitigate inventory losses attributable process deficiencies fraudulent behavior providing visibility transactions processed point sale systems in addition operate distribution centers fully integrated technology solutions storage product retrieval order picking retail pharmacy customers managed care organizations government funded health care programs including state medicaid plans medicare partd drug plans commercial employers third party plans accounted pharmacy revenues the loss one payor material effect business no single retail payor accounts total consolidated revenues however success retail drugstore business dependent upon ability establish maintain contractual relationships pbms payors acceptable terms in two nations largest pbms medco esi together accounted approximately retail pharmacy segment revenues during medco esi announced plans merge businesses subject various closing conditions regulatory approvals it remains unclear whether merger occur cannot predict impact proposed merger completed competitive landscape see item risk factors an extremely competitive business environment our contracts commercial payors government funded programs subject renegotiation reimbursement rates see government regulation reimbursement itema risk factors efforts reduce reimbursement levels alter health care financing practices retail pharmacy seasonality the majority revenues particularly pharmacy revenues generally seasonal nature however front store revenues tend higher decemberholiday season for additional information refer note quarterly financial information annual report stockholders year ended december section incorporated reference herein retail pharmacy competition the retail drugstore business highly competitive we believe compete principally basis istore location convenience iicustomer service satisfaction iiiproduct selection variety ivprice in markets serve compete drugstore chains supermarkets discount retailers independent pharmacies membership clubsinternet companies retail health clinics well mail order pharmacies pbms table contents corporate segment our corporate segment provides management administrative services support overall operations company the corporate segment consists certain aspects executive management corporate relations legal compliance human resources corporate information technology finance departments working capital practices we fund growth business combination cash flow operations commercial paper proceeds sales lease back transactions long term borrowings for additional information working capital practices refer caption liquidity capital resources annual report stockholders year ended december section incorporated reference herein the majority non pharmacy revenues paid cash debit credit cards managed care third party insurance programs typically settle less days represented approximately consolidated pharmacy revenues including retail pharmacy pharmacy services combined our customer returns significant associate development as december employed approximately associates included pharmacists nurse practitioners physician assistants in addition approximately associates part time employees work less hours per week to deliver highest levels service customers devote considerable time attention people service standards we emphasize attracting training knowledgeable friendly helpful associates work organization intellectual property we registered andor applied register variety trademarks service marks used throughout business we regard intellectual property significant value pharmacy services retail pharmacy segments we aware facts could materially impact continuing use intellectual property government regulation overview as participant health care industry retail pharmacy services businesses subject federal state laws regulations govern purchase sale distribution prescription drugs related services including administration management prescription drug benefits many pbm clients including insurers managed care organizations mcos subject extensive regulations affect design implementation prescription drug benefit plans sponsor the application complex legal regulatory requirements detailed operation business creates areas uncertainty there numerous proposed health care laws regulations federal state levels could adversely affect business enacted we unable predict federal state legislation regulatory initiatives may enacted future relating business health care industry general effect legislation regulations might business any failure alleged failure comply applicable laws regulations adverse applications changes laws regulations affecting business could material adverse effect operating results andor financial condition table contents anti remuneration laws federal law prohibits among things entity knowingly willfully offering paying soliciting receiving subject certain exceptions safe harbors remuneration induce referral individuals purchase lease order arranging recommending purchase lease order items services payment may made medicare medicaid certain federal health care programs number states similar laws limited services paid government funds state laws exceptions safe harbors vary infrequently interpreted courts regulatory agencies sanctions violating federal state anti remuneration laws may include imprisonment criminal civil fines exclusion participation medicare medicaid government sponsored health care programs the federal anti remuneration law interpreted broadly courts office inspector general oig within united states department health human services hhs administrative bodies broad interpretation federal anti remuneration law supported patient protection affordable care act health care education reconciliation act collectively ppaca codified reduced standard knowingly willfully stating standard require person actual knowledge federal anti remuneration law specific intent violate law ppaca also provides violation federal anti remuneration law constitutes false fraudulent act federal false claims act fca because federal statutes broad scope hhs established certain safe harbor regulations specify various practices protected criminal civil liability safe harbors exist certain discounts offered purchasers certain personal services arrangements certain payments made vendors group purchasing organizations certain cases provision electronic prescribing technology physicians certain transactions relationships practice fall within safe harbor necessarily unlawful may subject challenge hhs in addition part ppaca additional statutory exceptions created permit provision certain incentives federal health care program beneficiaries including retailer coupons rebates rewards incentives offered promote access care also waivers granted oig cms allow affordable care organization aco providers give certain free items services beneficiaries encourage adherence clinical goals drug regimen long items services encourage beneficiary seek care aco provider see item legal proceedings information antitrust unfair competition the federal trade commission ftc authority section federal trade commission act ftca investigate prosecute practices unfair trade practices unfair methods competition relief ftca encompass equitable relief consumer redress in addition numerous lawsuits filed throughout united states pharmaceutical manufacturers retail pharmacies andor pbms various state federal antitrust unfair competition laws challenging among things ibrand drug pricing practices pharmaceutical manufacturers iithe maintenance retail pharmacy networks pbms iiivarious business practices pbms retail pharmacies to extent appear actual potential market power relevant market business arrangements practices may subject heightened scrutiny anti competitive perspective possible challenge state federal regulators private parties see item legal proceedings information compliance programs ppaca requires health care providers enrolled medicare medicaid must establish maintain compliance programs satisfy core requirements established secretary hhs consultation oig the secretary hhs yet published information concerning compliance programs timeframe implementation in addition certain state government health care programs compliance program requirements subject various government agreements described government agreements also contain requirements relating maintenance compliance programs consumer protection laws the federal government states consumer protection laws basis investigations lawsuits multi state settlements relating among matters marketing loyalty programs health care services financial incentives provided drug manufacturers pharmacies connection therapeutic interchange programs in addition ftca bars unfair methods competition unfair deceptive acts practices affecting commerce the federal postal service act generally prohibits mailing billing unordered merchandise the ftcs telemarketing sales rulealso imposes extensive requirements restrictions connection telemarketing plans programs encourage purchase goods services consumers see telemarketing other outbound contacts section disclosures table contents contract audits we subject audits many contracts including pbm client contracts pbm rebate contracts pharmacy provider agreements contracts relating medicare partd audits typically conducted pursuant certain provisions pbm contracts provider agreements grant audit rights set forth applicable audit procedures because contracts state federal governments entities contracted state federal agencies audits agreements often regulated federal state agencies responsible administering federal state benefits programs including operate medicaid fee service plans managed medicaid plans medicare partd plans medicare advantage organizations the audits generally focus among things compliance applicable terms contracts applicable legal requirements disease management services regulation we provide arrange pbm plan members receive clinical services form disease management programs common rare medical conditions nurses pharmacists clinicians needed develop implement programs state laws regulate practice medicine practice pharmacy practice nursing clinicians engaged professional practice must satisfy applicable state licensing requirements electronic prescribing the federal government implemented different programs promote electronic prescribing including erx incentive program established medicare improvements patients providers act provides combination incentive payments payment adjustments eligible professionals successful electronic prescribers while program sunsets american recovery reinvestment act arra established incentive program eligible professionals hospitals participating medicare medicaid program adopt meaningfully use certified electronic health records ehr technology beginning arra also provides downward payment adjustments beginning eligible professionals medicare program fail adopt meaningfully use certified ehr technology electronic prescribing final ruleimplementing ehr incentive program issued july requires least permissible prescriptions sent electronically order qualify incentive payments in march us drug enforcement administration dea issued interim final ruleallowing electronic prescribing controlled substances beginning june these changes together requirement medicare partd plans support electronic prescribing result growing number prescribers adopting electronic prescribing environmental regulation our business subject various federal state local laws regulations requirements pertaining protection environment public health including example regulations governing management waste materials waste waters governmental agencies federal state local levels recent years increasingly focused retail sectors compliance laws regulations times pursued enforcement activities there also increased interest regulators better managing photo processing well pharmaceutical wastes our retail pharmacies subject various state environmental agency enforcement actions periodically receive information requests notices potential noncompliance environmental laws regulations governmental agencies erisa regulation the employee retirement income security act amended erisa provides comprehensive federal regulation certain employee pension benefit plans including private employer union sponsored health plans certain plans contract us provide pbm services in general assist plan sponsors administration prescription drug portion health benefit plans accordance plan designs adopted plan sponsors we believe conduct business subjects us fiduciary obligations erisa except specifically contracted plan sponsor accept limited fiduciary responsibility adjudication initial prescription drug benefit claims andor appeals denied claims plan we pbms named lawsuits alleging act fiduciary term defined erisa respect health benefit plans breached certain fiduciary obligations erisa table contents erisa fiduciaries may held personally liable entering service contracts arrangements like pbm contracts behalf erisa plans terms contract reasonable service provider receives reasonable compensation services provided in cases service provider may also required disgorge unreasonable compensation received may subject civil penalties imposed us department labor dol in addition fiduciary provisions erisa imposes civil criminal liability service providers health plans certain persons certain forms illegal remuneration made received these provisions erisa similar identical health care anti remuneration statutes discussed although erisa lacks statutory regulatory safe harbor exceptions incorporated health care statutes similar health care statutes corresponding provisions erisa broadly written application specific business practices often uncertain most pension welfare plans subject erisa required report dol compensation paid service providers in addition dol announced project promulgate regulations erisa could require service providers including pbms provide detailed disclosure regarding direct indirect compensation received connection services provided well potential conflicts interest the dol issued supplemental frequently asked questions specifically addressed pbm disclosure certain compensation including ifees services dispensing fees administrative fees reportable direct compensation iidiscounts rebates received pbms pharmaceutical companies pending guidance dol generally need treated reportable indirect compensation further guidance expected dol cannot certain extent possible future disclosure regulations may impact business state laws discussed government regulation section may applicable us plan sponsors customers may preempted whole part erisa however scope erisa preemption uncertain subject conflicting court rulings false claims fraudulent billing statutes range federal civil criminal laws target false claims fraudulent billing activities one significant laws fca prohibits submission false claim making false record statement order secure reimbursement limit reimbursement government sponsored program the fraud enforcement recovery act fera implemented substantial changes fca expand scope fca liability provide new investigative tools make easier qui tam relators often referred whistleblowers bring maintain fca suits behalf government ppaca eased burden whistleblowers bring maintain fca suits modifying public disclosure original source provisions fca some states passed substantially similar acts in recent years federal state governments launched several initiatives aimed uncovering practices violate false claims fraudulent billing laws fera also expanded fca cover improperly avoiding obligation pay money government ppaca clarified retention overpayments beyond repayment deadline violation fca in addition ppaca provides violation federal anti remuneration law constitutes false fraudulent act fca expands jurisdiction fca health insurance exchanges created ppaca ppaca also provides imposition civil monetary penalties knowingly making causing made false fraudulent record statement material false fraudulent claim payment government sponsored program knowingly failing report return overpayment false statements provider enrollment applications the federal deficit reduction act dra example requires certain entities receive make annual medicaid payments certain amount provide employees certain contractors agents certain information regarding federal state false claims acts whistleblower protections entitys processes detecting preventing fraud waste abuse claims laws may brought either government private individuals behalf government qui tam whistleblower action discussed detail elsewhere government regulation section in recent years federal state government authorities launched several initiatives aimed uncovering practices violate false claims fraudulent billing laws conducted numerous investigations pharmaceutical manufacturers pbms pharmacies health care providers respect false claims fraudulent billing related matters see item legal proceedings information table contents fda regulation the united states food drug administration fda generally authority regulate drugs drug classifications drug promotional information materials disseminated drug manufacturer persons behalf drug manufacturer the fda also regulatory authority many products sold retail pharmacies including certain food items cosmetics dietary supplements otc medications we previously operated fda regulated repackaging facility repackaged certain drugs common prescription quantities dispensed mail service pharmacies closed repackaging facility april the fda also may inspect facilities connection procedures implemented effect recalls prescription drugs fda regulated products well procedures comply food safety regulations in addition fda authority require submission implementation risk evaluation mitigation strategy rems fda determines rems necessary safe effective marketing drug to extent dispense products subject rems requirements provide rems services pharmaceutical manufacturers subject audit fda pharmaceutical manufacturer the fda also regulatory authority medical devices otc genetic tests genetic tests conducted medical laboratories fda continues evaluate need regulation tests federal employee health benefits program we contractual arrangement bluecross blueshield association bcbsa provide pharmacy services federal employees postal workers annuitants dependents government wide service benefit plan authorized federal employees health benefits act fehba part federal employees health benefits program fehbpthis arrangement subjects us fehba fehba regulations including federal employees health benefits acquisition regulation office personnel management guidelines certain federal acquisition regulations these laws regulations guidelines govern process federal government contracts health insurance carriers bcbsa participate fehbp obligate health insurance carriers impose various contractual requirements contract vendors including among things requirements relating transparency performance standards drug interchanges patient safety consumer access coordination benefits pricing adjustments recordkeeping audits formulary regulation number states begun regulate administration prescription drug benefits for example states passed laws mandating coverage label uses drug products uses recognized peer reviewed medical journals reference compendia other states enacted laws regulate development use formularies insurers mcos third party payors these laws included requirements development review update formularies role composition pharmacy therapeutics committees disclosure formulary information health plan members process allowing members obtain non preferred drugs without additional cost sharing medically necessary determined clinically appropriate additionally national association insurance commissioners naic developed model law health carriers prescription drug benefit management model act addresses formulary regulation issues risk bearing entities regulated state insurance commissioners could form basis state legislation the mma also regulates formularies developed administered beneficiaries medicare partd in july congress enacted medicare improvements patients providers act requires secretary hhs identify certain classes categories drugs subject certain exceptions drugs class category must included medicare partd plans formulary the increasing government regulation formularies could significantly affect ability develop administer formularies behalf insurer mco clients government agreements our pbm business subject terms consent order entered number states impacting certain pbm business practices including matters relating relationships clients pharmaceutical manufacturers retail pharmacies plan members prescribers pharmacists in march company entered settlement agreement federal government number states related dispensing generic drug ranitidine retail pharmacies at time company entered corporate integrity agreement oig period five years applicable certain retail mail service operations company this corporate integrity agreement requires among things maintenance compliance program employee training specific reviews independent review organization various government reporting obligations in april entered amendment corporate integrity agreement connection previously announced settlement federal state government investigation certain retail pharmacy billing practices respect dual eligible customers medicaid coverage third party insurance coverage this amendment requires company comply corporate integrity agreement amended period three years requires among things additional employee training obligations additional reporting obligations periodic medicaid billing reviews independent review organization failure meet obligations corporate integrity agreement amended could result stipulated financial penalties failure comply material terms could lead exclusion applicable business participation federal health care programs in january entered separate settlement agreements ftc hhs office civil rights ocr resolving joint investigation prompted media reports disposal patient information dumpsters limited number cvspharmacy locations as part ftc settlement agreed maintain appropriate enterprise wide information security policies procedures twenty year term agreement the ftc settlement also provides periodic compliance table contents monitoring external assessor as part ocr settlement agreed maintain appropriate waste disposal policies procedures training employee sanctions retail stores the ocr settlement three year term provides annual compliance monitoring external assessor in october company entered non prosecution agreement civil settlement agreement us department justice doj various united states attorneys offices relating sale distribution pseudoephedrine products certain cvspharmacy stores primarily california nevada the company also entered related memorandum agreement dea the non prosecution agreement memorandum agreement contain certain ongoing compliance requirements company failure comply terms documents could lead civil criminal remedies financial penalties andor administrative remedies dea registrations retail pharmacies distribution centers in january company announced agreement ftc enter proposed consent order would prohibit company misrepresenting prices costs medicare partd prescription drugs prices costs associated medicare partd prescription drug plans this proposed consent order accepted ftc public comment remains subject final approval in addition government agreements described company andor various affiliates subject consent decrees settlement agreements various federal state local authorities may contain certain ongoing reporting monitoring compliance requirements company these agreements relate matters privacy practices waste disposal practices selling expired products environmental safety matters tobacco sales marketing advertising practices pharmacy operations various business practices health reform legislation congress passed major health reform legislation known ppaca this legislation affects entire health insurance system virtually every aspect health care country although many provisions ppaca effective immediately given many regulations implementing ppaca still finalized ongoing sub regulatory guidance still issued considerable uncertainty full impact further aspects legislation challenged lawsuits across country congress seeking repeal law portions there already number conflicting court rulings calling question constitutionality certain portions ppaca additional judicial review including review united states supreme court expected in addition establishing framework every individual health coverage beginning ppaca enacted number significant health care reforms while reforms may affect business directly affect coverage plan designs provided many health plan clients as result could indirectly impact many services business practices among significant ppaca provisions requirement health insurers meet minimum medical loss ratio mlr avoid pay rebates enrollees the mlr requires insurers break clinical quality improvement administrative costs hhs issued interim final regulation mlr december includes example could interpreted suggest differential drug price charged pbms health plans amount reimbursed retail pharmacies commonly referred differential spread excluded claims costs subsequent sub regulatory guidance remained consistent interpretation although made clear clinical services performed pbm could included claims costs health plan clients subject mlr requirements may request pricing modifications include requests contract pbm using pass retail network pricing another ppaca provision requires pbms contract medicare partd plan qualified health plan offered health insurance exchange disclose certain information hhs medicare partd plan health insurance exchange among information must disclosed generic dispensing rate different types pharmacies aggregate amount types rebates discounts negotiated behalf passed plan aggregate amount differential although items differential required reported partd per cms guidance full reporting required medicare partd upon issuance final ruleimplementing requirements expected qualified health plans upon implementation health insurance exchanges established ppaca ppaca also increases obligations partd plan sponsors report rebates price concessions pharmaceutical manufacturers enable calculation new annual fees imposed pharmaceutical manufacturers related branded drug sales ppaca also made significant changes medicare medicaid programs fraud abuse laws tax provisions discussed elsewhere government regulation section managed care reform in addition health reforms enacted ppaca proposed legislation considered state level legislation enacted several states aimed primarily providing additional rights access drugs individuals enrolled managed care plans this legislation may impact design implementation prescription drug benefit plans sponsored pbm health plan clients andor services provide some initiatives would among things irequire health plan members greater access drugs included plans formulary iigive health plan members right sue health plans malpractice denied care andor iiimandate content appeals grievance process health plan member denied coverage both scope managed care reform proposals table contents considered state legislatures reforms enacted states date vary greatly scope future legislation may enacted uncertain medicare partd the mma created medicare partd medicare drug benefit program january medicare beneficiaries entitled medicare benefits parta enrolled medicare partb eligible drug coverage medicare partd regulations implementing medicare partd included requirements relating developing administering formularies establishing pharmacy networks marketing medicare partd plans processing adjudicating claims point sale compliance electronic prescribing standards the medicare partd program undergone significant legislative regulatory changes since inception including changes made ppaca effective plan year cms issued regulation requiring differential spread reported administrative cost rather drug cost plan sponsor purposes calculating certain government subsidy payments drug price charged enrollees this change resulted medicare partd plan sponsors contracting pass pricing retail networks rather pricing included use retail network differential spread ppaca expanded medicare partd benefit effective plan year implementing coverage gap discount program participating manufacturers fund discounts brand drugs obtained coverage gap donut hole starting phase coverage gap generic drugs completed ppaca also requires secretary hhs develop rulesfor shorter dispensing periods enrollees long term care facilities order reduce waste several ppaca changes require significant adjudication reporting systems modifications in october cms issued proposed ruleon partd among things would establish daily cost sharing rate form drug utilization management certain fraud waste abuse controls the proposed rulealso permits cms terminate partd sponsors contract performs poorly cms performance criteria known star ratings three consecutive years medicare partd continues attract high degree legislative regulatory scrutiny applicable government rulesand regulations continue evolve accordingly possible legislative regulatory developments could materially affect medicare partd business profitability mental health parity legislation the paul wellstone pete domenici mental health parity addiction equity act implementing regulations require group health plans provide medicalsurgical benefits mental health substance abuse disorder benefits ensure financial requirements treatment limitations apply mental health substance abuse disorder benefits restrictive apply medicalsurgical benefits while implementing regulations contain special ruleallowing multi tiered prescription drug benefits meet certain conditions considerable uncertainty regarding application rule this caused group health plans consider dropping mental health benefits including drugs treat conditions avoid found violation regulation network access legislation majority states form legislation affecting ability limit access pharmacy provider network remove network providers certain willing provider legislation may require us clients admit non participating pharmacy pharmacy willing able meet plans price applicable terms conditions network participation these laws vary significantly state state regard scope requirements application erisa plans payors challenged application laws basis erisa preemption however scope erisa preemption uncertain subject conflicting court rulings in addition mma contains willing provider requirement pharmacy participation medicare partd cms interpreted requiring medicare partd sponsor type pharmacy network allow participation pharmacy meets applicable terms conditions participation to extent state federal willing provider laws determined apply us certain clients pharmacy networks manage pbm clients laws could negatively impact services economic benefits achievable limited pharmacy provider network some states also enacted due process legislation may iprohibit removal provider pharmacy network andor iiimpact conduct audits network pharmacies recover audit discrepancies except compliance certain procedures other state legislation prohibits days supply limitations co payment pricing differentials mail service retail pharmacy providers in addition medicare partd cms requires partd sponsor offers day supply mail must allow retail network pharmacies also offer day supply terms pbm laws regulation legislation seeking regulate pbm activities comprehensive manner introduced enacted number states this legislation varies scope often contains provisions iimpose certain fiduciary duties upon pbms clients plan members iirequire pbms disclose andor remit clients plan members certain rebates discounts amounts received pbms related sale drugs iiiregulate product substitution intervention ivimpose broad disclosure obligations upon pbms clients plan members andor vimpose licensing registration requirements to extent states government entities enact legislation regulating pbms survive legal challenges table contents enforceability legislation could adversely impact ability conduct business commercially reasonable terms locations legislation effect in addition certain quasi regulatory organizations including national association boards pharmacy naic issued model regulations may propose future regulations concerning pbms andor pbm activities similarly credentialing organizations national committee quality assurance utilization review accreditation commission urac may establish voluntary standards regarding pbm specialty pharmacy activities for example urac issued pbm accreditation standards pbms serving commercially insured market caremark currently accredited pbm urac while actions quasi regulatory standard setting organizations force law may influence states adopt requirements recommendations influence client requirements pbm specialty pharmacy services moreover standards established organizations could also impact health plan clients andor services provide in addition state statutes regulations also subject state common laws extent applied pbms judicial interpretation otherwise potential common law claims could involve example breach fiduciary duty constructive fraud fraud unjust enrichment pharmacy professional licensure regulation we subject state federal statutes regulations governing operation retail mail pharmacies repackaging drug products wholesale distribution dispensing controlled substance listed chemical products medical controlled substance waste disposal federal state statutes regulations govern labeling packaging advertising adulteration prescription drugs dispensing controlled substances state regulations require compliance standards established united states pharmacopeia respect packaging storing shipping pharmaceuticals federal state controlled substance laws require us register pharmacies distribution centers dea state controlled substances agencies comply security recordkeeping inventory control personnel labeling standards order possess dispense controlled substances listed chemical products we also subject regulation dea state pharmacy boards connection online pharmacies dispense prescription drugs pursuant refill orders received internet websites among methodsnumerous state laws also exist affecting ourreceipt processing electronic prescription drug orders certain violations federal controlled substances laws subject company pharmacies distribution centers individual pharmacy personnel criminal civil penalties also result administrative action dea including suspension revocation pharmacys distribution centers registration distribute controlled substances andor listed chemical products state authorities state boards pharmacy similarly authority impose monetary penalties disciplinary sanctions including revocation pharmacys individual pharmacists license dispense controlled substances penalties sanctions addition sanctions imposed federal controlled substances laws certain violations federal state legal requirements also trigger consequences companysbusiness could potentially impact eligibility participate federal health careprograms other statutes regulations may affect mail service operations for example ftc requires mail service sellers goods generally engage truthful advertising stock reasonable supply products sold fill mail service orders within thirty days provide clients refunds appropriate in addition united states postal service department transportation regulatory authority restrict transmission drugs medicines mail commerce statelicensing authorities may restrictthe types personnel may work mail service operations our pharmacists technicians certain health care professionals subject state regulation profession employees engaged professional practice must satisfy applicable state licensing registration requirements comply applicable professional standards in addition must comply applicable federal state requirements participation government sponsored health care programs failure comply requirements could subject us employees disciplinary action including fines penalties sanctions could impact ability obtain retain reimbursement services provided participants government sponsored health care programs andor could cause licenses permits employees licenses suspended revoked table contents plan design legislation some states enacted legislation prohibits health plan sponsor implementing certain restrictive design features many states introduced legislation regulate various aspects managed care plans including provisions relating pharmacy benefits for example states adopted freedom choice legislation provides imembers plan may required use network providers must instead provided benefits even choose use non network providers iia plan member may sue health plan care denied various states enacted considered enacting legislation regarding plan design mandates including legislation prohibits restricts therapeutic interchange requires coverage drugs approved fda prohibits denial coverage non fda approved uses some states mandate coverage certain benefits conditions ppaca requires coverage certain preventive services cost sharing such legislation generally apply us may apply certain clients generally mcos health insurers other states enacted legislation purporting prohibit health plans covered erisa requiring offering members financial incentives use mail service pharmacies use certain health care providers legislation imposing plan design mandates may apply certain clients could effect limiting economic benefits achievable pbm services provide privacy confidentiality requirements many activities involve receipt use disclosure us personally identifiable information pii permitted accordance applicable federal state privacy data security laws require organizations provide appropriate privacy protections security safeguards information in addition pii use disclose de identified data analytical purposes the federal health insurance portability accountability act regulations issued thereunder collectively hipaa impose extensive requirements way health plans health care providers health care clearinghouses known covered entities business associates use disclose safeguard protected health information phi hipaa also gives individuals certain rights respect phi for uses disclosures phi treatment payment health care operations certain public policy purposes hipaa generally requires covered entities obtain individuals written authorization criminal penalties civil sanctions may imposed failing comply hipaa standards during ocr continued promulgate new updated non final regulations response health information technology economic clinical health act hitech act part arra contained significant legislative changes hipaa privacy security rules these changes included restrictions use phi without individuals written authorization requirement account routine disclosures phi held electronic health record requirement notify individuals breaches phi enforcement rights state attorneys general extension federal privacy security law provisions penalties business associates covered entities increased penalties violation law while provisions hitech act already effect final regulations regarding hipaa privacy security enforcement data breach rulesare yet issued in may hhs published notice proposed rulemaking nprm address changes requirements surrounding accounting disclosures included new requirement hipaa covered entity report individual internal uses disclosures electronic phi if hhs adopts nprm currently written could generate substantial burdens costs company business associates implement fully nevertheless since rules implementing proposal much hitech act yet finalized cannot time determine extent changes may apply impact business in addition hipaa states enacted health care information confidentiality laws limit disclosure confidential medical information these state laws supersede hipaa extent protective individual privacy hipaa most states also enacted legislation regulations governing security pii specifying notification requirements security breaches involving pii in addition hipaa hitech genetic information nondiscrimination act gina signed law may proposed interim final regulations issued gina prohibits discrimination based genetic information health coverage title employment title ii under gina health plans permitted use disclose genetic information underwriting purposes includes eligibility determinations they also may collect genetic information requiring genetic testing except limited circumstances reimbursement significant portion net revenue derived directly medicare medicaid government sponsored health care programs therefore subject among laws regulations federal state reimbursement laws regulatory requirements anti remuneration laws stark law andor federal state false claims laws sanctions violating federal andor state laws may include without limitation recoupment reduction government reimbursement amounts criminal civil penalties exclusion participation medicare medicaid government health care programs also provide products services managed care entities provide services beneficiaries medicare medicaid government sponsored health care programs well employers entities qualify medicare partd drug subsidy andor early retiree reinsurance program created ppaca some federal state laws regulations impose requirements pbm retail pharmacies coordinate benefits among private health plans table contents government sponsored health care programs customer plan member benefits coverage one insurance company payor in addition pbm contractual agreements process behalf pbm clients reimbursement claims submitted behalf federal state government agencies following payment government agencies claims submitted members private health plans primary source benefits coverage these claims commonly known pay chase claims pbm clients subject federal state laws regulations impacting claims processed reimbursed see item legal proceedings information the federal government numerous state governments given increased attention pharmaceutical manufacturers develop report pricing information turn used setting payments medicare medicaid programs one element common payment formulas average wholesale price awp come criticism allegedly inaccurately reflecting prices actually charged paid wholesale level the calculation reporting awp subject investigations federal state governments litigation brought pharmaceutical manufacturers data services report awp we responsible calculations reports payments awp however investigations lawsuits could impact business many client contracts pharmaceutical purchase agreements retail network contracts agreements use awp pricing benchmark in conjunction class action settlement implemented september involving first databank fdb medi span two entities publish awp pharmaceuticals methodology used calculate awp modified manner reduced awp many brand drugs generic drugs we reached understandings pbm clients third party payors adjust reimbursements account change methodology state medicaid programs utilize awp pricing reference taken action make similar adjustments as result experienced reduced medicaid reimbursement certain products since settlement implemented in addition fdb discontinued publishing awp september although medi span continues publish awp possible pharmaceutical industry may evaluate andor develop alternative pricing reference replace awp we continue work pbm clients payors anticipate mitigate impact possible future changes applicable references pricing pharmaceuticals awp already replaced average sales price asp basis reimbursing physicians sometimes pharmacies outpatient prescription drugs medicare partb the federal medicaid rebate program requires participating drug manufacturers provide rebates drugs purchased state medicaid programs investigations commenced certain governmental entities question whether best price available essentially client medicaid program best price properly calculated reported paid manufacturers medicaid programs we responsible calculations reports payments best price however investigations could impact ability negotiate rebates drug manufacturers ppaca increased amount rebates required paid manufacturers medicaid program also imposes certain annual fees pharmaceutical manufacturers we anticipate increased medicaid rebate levels annual fees impact discounts obtain pharmaceutical companies ppaca made several significant changes medicaid rebates reimbursement one revise definition average manufacturer price amp reimbursement formula multi source ie generic drugs based federal upper limits ful established cms on january cms released proposed ruleto interpret implement changes cms proposing set ful multi source drug reimbursement amp the ful would established multi source drug fda rated three products therapeutically pharmaceutically equivalent would based weighted average recently reported monthly amps products among things proposed cms rulealso proposes changes medicaid drug reimbursement payment methodologies medicaid best price regulations it uncertain extent proposed changes may impact medicaid reimbursement rates cms seeking comments proposed rulethrough april stated intends issue final rulein because proposed status rule cannot yet predict impact proposed ruleon company cms also issued draft affordable care act ful methodology data elements guide together draft files fuls cms seeking comment prior publishing final fuls the final fuls take effect without regard whether final regulations promulgated cms provided guidance final fuls published certain state medicaid programs allow reimbursement pharmacies residing state border state while believe service current medicaid customers existing pharmacies assurance additional states enact state dispensing requirements medicaid programs some states adopted legislation regulations requiring pharmacy participating state medicaid program give state best price pharmacy makes available third party payor states enactedlegislation regulations impacting thedefinition pharmacys usual customary price uc including whether pricing offered pharmacies pursuant discount cardor similar programsshould considered determining uc these requirements sometimes referred favored nation pricing payment systems other states enacted unitary pricing legislation mandates wholesale purchasers drugs within state given access discounts incentives number states also recently introduced legislation seeking control drug prices various statutory limits rebates discounts extending one categories states population table contents changes reporting awp amp asp adjustments may made regarding reimbursement drug payments medicaid medicare could impact pricing customers payors andor could impact ability negotiate discounts rebates manufacturers wholesalers pbms retail mail pharmacies in circumstances changes could also impact reimbursement receive medicare medicaid programs drugs covered programs mcos contract government health programs provide prescription drug benefits reimportation the mma amended food drug cosmetic act providing fda promulgate rulesthat would permit pharmacists wholesalers import prescription drugs canada united states certain circumstances however promulgation rulesis subject precondition fda certify congress reimportation would pose additional risk publics health safety would result significant cost reduction to date fda provided certification under certain defined circumstances fda used discretion permit individuals physicians bring us small quantities drugs treatment patients serious condition effective treatment available us congress expanded personal use policy specific circumstances allow individuals personally transport canada personal use day supply prescription drug regardless availability us the language allow purchases mail order via internet excludes biologics controlled substances the fda continues strongly oppose efforts allow widespread importation drugs canada elsewhere citing concerns activities undermine fdas ability oversee quality safety nations drug supply if fda changes position permits broader importation drugs canada future new pending health legislation regulations permit importation drugs european union countries future pharmacy services could impacted retail clinics states also regulate retail clinics operated nurse practitioners physician assistants physician oversight lab licensing prohibition corporate practice medicine number states implemented proposed laws regulations impact certain components retail clinic operations physician oversight signage third party contracting requirements bathroom facilities scope services these laws regulations may affect operation expansion owned managedretail clinics retiree drug subsidy the mma created drug subsidy program available certain employer union group plans provides retiree coverage medicare partd eligible individuals least equivalent medicare partd coverage the subsidy equal drug costs currently tax free however plan years beginning ppaca eliminates tax deductibility retiree drug subsidy payment received sponsors retiree drug plans this may cause employers transition retirees employer sponsored medicare partd plans as part ppaca congress established new temporary early retiree reinsurance program providing reimbursement employer union sponsors participating employment based plans portion cost health benefits early retirees aged spouses surviving spouses dependents the program reimburses sponsors certain claims congress appropriated funding billion temporary program became effective june the program ends funding exhausted later january safety regulation the occupational safety health act amended osha establishes certain employer responsibilities including maintenance workplace free recognized hazards likely cause death serious injury compliance standards promulgated osha various record keeping reporting procedural requirements many osha standards well various state local laws regulations pertaining employee safety health apply operations any failure comply regulations could result fines sanctions government authorities self referral laws the federal law commonly known stark law prohibits physician referring medicare medicaid beneficiaries designated health services include among things outpatient prescription drugs home health services durable medical equipment supplies entity physician immediate family member physician financial relationship prohibits entity receiving prohibited referral presenting claim medicare medicaid designated health service furnished prohibited referral possible penalties violation stark law include denial payment refund amounts collected violation statute civil monetary penalties medicare medicaid program exclusion the stark law contains certain statutory regulatory exceptions physician referrals physician financial relationships including certain physician consulting arrangements fair market value purchases physicians provision electronic prescribing technology physicians state statutes regulations also prohibit payments referral individuals physicians health care providers physicians financial relationship some state statutes regulations apply services reimbursed governmental well private payors violation laws may result prohibition payment services rendered loss pharmacy health care provider licenses fines criminal penalties the laws exceptions safe harbors may vary federal stark law vary significantly state state the laws often vague many cases interpreted courts regulatory agencies table contents state insurance laws fee service pdps pbm service contracts including assume certain risk performance guarantees similar arrangements generally subject insurance regulation states however pbm offers provide prescription drug coverage capitated basis otherwise accepts material financial risk providing pharmacy benefits laws regulations various states may applicable such laws may require party risk become licensed insurer establish reserves otherwise demonstrate financial viability laws may apply cases include insurance laws laws governing mcos limited prepaid health service plans during company offered pdps silverscript accendo insurance subsidiaries pennsylvania life insurance subsidiary acquired part uam medicare partd business april these insurance subsidiaries must licensed risk bearing entity applicable state laws must obtained waiver licensing requirement cmseach subsidiaries licensed states offer pdps operate medicare partd waivers as licensed insurance companies subject various state insurance regulations generally require among things maintenance capital surplus requirements review certain material transactions filing various financial licensing operational reports pursuant mma state insurance licensing insurance agentbroker licensure solvency laws regulations generally applicable pdps application state laws medicare partd generally preempted medicare partd extent medicare partd regulates issue some states laws prohibit submitting false claim making false record statement order secure reimbursement insurance company these state laws vary violation may lead imposition civil criminal penalties additionally several states passed legislation governing prompt payment claims requires among things health plans payors pay claims within certain prescribed time periods pay specified interest penalties these laws vary state state regard scope requirements application clear extent may apply clients us certain health plans payors may exempt laws basis erisa preemption scope erisa preemption unclear state prescription drug assistance programs many states established modified drug assistance programs elderly constitute qualified state pharmacy assistance programs spaps supplement medicare partd payments qualified spaps behalf medicare partd enrollee treated medicare partd made enrollees thereby counting towards enrollees true pocket costs helping qualify catastrophic coverage sooner medicare partd plans required coordinate benefits spaps including allowing spaps subsidize medicare partd premiums members andor medicare partd cost sharing some qualified spaps state authorization also received permission cms enroll members choose medicare partd plans pdps telemarketing other outbound contacts certain federal state laws give ftc federal communications commission state attorneys general law enforcement tools regulate telemarketing practices certain automated outbound contacts phone calls texts emails these laws may among things impose registration requirements require disclosures specific information prohibit misrepresentations limit consumers may contacted require consumer consent prior contacted require transmission caller id information prohibit certain abandoned outbound calls prohibit unauthorized billing set payment restrictions sale certain goods services require establishment certain policies training personnel require retention specific business records third party administration other state licensure laws many states licensure registration laws governing certain types administrative organizations preferred provider organizations third party administrators companies provide utilization review services several states also licensure registration laws governing organizations provide administer consumer card programs also known cash card discount card programs the scope laws differs significantly state state application laws activities often unclear whistleblower statutes certain federal state laws including fca contain provisions permitting filing qui tam whistleblower lawsuits alleging violations laws whistleblower provisions allow private individuals bring lawsuits behalf federal state government alleging defendant defrauded government generally minimum evidentiary legal threshold required bringing lawsuit these lawsuits typically filed seal applicable federal state enforcement authority authority required review allegations made determine whether intervene lawsuit take lead litigation if government intervenes lawsuit prevails whistleblower plaintiff filing initial complaint may share settlement judgment if government intervene lawsuit whistleblower plaintiff may pursue action independently because qui tam lawsuit typically filed seal pending government review allegations defendant generally may aware lawsuit government determines whether intervene lawsuit otherwise unsealed process may take years see item legal proceedings information table contents we believe material compliance existing laws regulations applicable retail pbm businesses we implemented standard operating procedures internal controls compliance integrity program designed help ensure compliance monitor legislative judicial developments could impact business practices effort ensure future compliance we give assurance however business financial condition results operations materially adversely affected required materially change business practices based ifuture enactment new health care laws regulations iithe interpretation application existing laws regulations including laws regulations described government regulation section may relate business pharmacy services retail pharmacy retail clinic industry health care industry generally iiipending future federal state governmental investigations business pharmacy services retail pharmacy retail clinic industry health care industry generally ivinstitution government enforcement actions us vadverse developments pending qui tam lawsuit us whether sealed unsealed future qui tam lawsuit may filed us viadverse developments pending future legal proceedings us affecting pharmacy services retail pharmacy retail clinic industry health care industry generally available information cvs caremark corporation delaware corporation our corporate office located one cvs drive woonsocket rhode island telephone our common stock listed new york stock exchange trading symbol cvs general information cvs caremark available companys web site httpinfocvscaremarkcom our financial press releases filings securities exchange commission available free charge within investors section web site httpwwwcvscaremarkcominvestors in addition sec maintains internet site contains reports proxy information statements information regarding issuers company file electronically sec the address web site httpwwwsecgov itema risk factors our business subject various industry economic regulatory risks uncertainties our business financial position results operations could materially adversely affected one following risk factors additional risks uncertainties presently known us currently deem immaterial the health economy general markets serve our business affected economy general including changes consumer purchasing power preferences andor spending patterns these changes could affect drug utilization trends well financial health number covered lives pbm clients resulting adverse effect business financial results in regard economic recession resulted declining drug utilization trends continued although recovery might underway possible worsening economic environment cause decline drug utilization dampen demand pharmacy benefit management services well consumer demand products sold retail stores further interest rate fluctuations changes capital market conditions regulatory changes may affect ability obtain necessary financing acceptable terms ability secure suitable store locations acceptable terms ability execute sale leaseback transactions acceptable terms efforts reduce reimbursement levels alter health care financing practices the continued efforts health maintenance organizations managed care organizations pbm companies government entities third party payors reduce prescription drug costs pharmacy reimbursement rates may impact profitability in particular increased utilization generic pharmaceuticals normally yield higher gross profit rate equivalent brand named drugs resulted pressure decrease reimbursement payments retail mail order pharmacies generic drugs causing reduction generic profit rate historically effect trend generic profitability mitigated companys efforts negotiate reduced acquisition costs generic pharmaceuticals manufacturers however recent years significant consolidation within generic manufacturer industry possible dynamic may enhance ability manufacturers sustain increase pricing generic pharmaceuticals diminish ability company negotiate reduced acquisition costs table contents in addition past several years us health care industry subject increase governmental regulation federal state levels efforts control health care costs including prescription drug costs underway federal state government levels changing political economic regulatory influences may significantly affect health care financing reimbursement practices ppaca made several significant changes medicaid rebates reimbursement one changes revise definition amp reimbursement formula multi source ie generic drugs cms recently issued proposed ruleto interpret implement changes proposed rulealso proposes changes medicaid drug reimbursement payment methodologies medicaid best price regulations cms seeking comments proposed rulethrough april stated intends issue final rulein because proposed status rule cannot yet predict impact company in addition ppaca made changes affect coverage plan designs provided many health plan clients including requirement health insurers meet minimum mlr avoid pay rebates enrollees these ppaca changes may affect business directly could indirectly impact services andor business practices the possibility pbm client loss andor failure win new pbm business our pbm business generates net revenues primarily contracting clients provide prescription drugs related health care services plan members pbm client contracts often terms approximately three years duration approximately one third pbms client base typically subject renewal year in cases however pbm clients may negotiate shorter longer contract term may require early periodic renegotiation pricing prior expiration contract therefore face challenges competing new pbm business retaining renewing pbm business none pbm clients represented companys consolidated revenues there assurance able win new business secure renewal business terms favorable company present terms risks related frequency rate introduction generic drugs brand name prescription products the profitability retail mail order pharmacy businesses dependent upon utilization prescription drug products utilization trends affected among factors introduction new successful prescription pharmaceuticals well lower priced generic alternatives existing brand name products accordingly business could impacted slowdown introduction new successful prescription pharmaceuticals andor generic alternatives sale normally yield higher gross profit margins brand name equivalents risks declining gross margins pbm industry the pbm industry experiencing margin pressure result competitive pressures increased client demands lower prices enhanced service offerings andor higher service levels in regard company maintains contractual relationships generic pharmaceutical manufacturers brand name pharmaceutical manufacturers provide purchase discounts andor rebates drugs dispensed pharmacies retail network mail order pharmacies portion may passed clients manufacturer rebates often depend pbms ability meet contractual market share requirements including cases placement manufacturers products pbms formularies competitive pressures pbm industry caused caremark pbms share clients larger portion rebates andor discounts received pharmaceutical manufacturers in addition market dynamics regulatory changes impacted ability offer plan sponsors pricing includes use retail differential spread could negatively impact future profitability further changes existing federal state laws regulations adoption new laws regulations relating patent term extensions purchase discount rebate arrangements pharmaceutical manufacturers formulary management pbm services could also reduce discounts rebates receive table contents regulatory business changes relating participation medicare partd since inception medicare partd resulted increased utilization decreased pharmacy gross margin rates higher margin business cash state medicaid customers migrated medicare partd coverage further result medicare partd result expected elimination tax deductibility retiree drug subsidy payment received sponsors retiree drug plans pbm clients could decide discontinue providing prescription drug benefits medicare eligible members to extent occurs adverse effects increasing customer migration medicare partd may outweigh benefits realize growth medicare partd business in addition cost complexity medicare partd exceed managements expectations prevent effective program implementation administration changes regulations regarding drug costs reported medicare partd retiree drug subsidy purposes implemented manner impacts profitability medicare partd business government alters medicare program requirements reduces funding higher anticipated cost taxpayers medicare partd reasons fail design maintain programs attractive medicare participants cms imposes sanctions restrictions medicare partd business result audits regulatory actions fail effectively integrate operate medicare partd businesses acquired successful retaining enrollees winning contract renewals new contracts medicare partds competitive bidding process medicare partd services ability expand medicare partd services could impacted possible changes industry pricing benchmarks implementation fdb medi span settlements described government regulation section resulted changes methodology used calculate awp pricing reference used many pbm client contracts pharmaceutical purchase agreements retail network contracts specialty payor agreements contracts third party payors following settlements fdb discontinued publishing awp september although medi span continues publish awp possible pharmaceutical industry may evaluate andor develop alternative pricing reference replace awp future changes use awp published pricing benchmarks used establish pharmaceutical pricing including changes basis calculating reimbursement federal state health programs andor payors could impact reimbursement receive medicare medicaid programs reimbursement receive pbm clients payors andor ability negotiate rebates andor discounts pharmaceutical manufacturers wholesalers pbms retail pharmacies the effect possible changes business cannot predicted time an extremely competitive business environment each retail pharmacy business pbm business currently operates highly competitive evolving health care environment our competitive success impacted ability retail pharmacy business establish maintain contractual relationships pbms payors acceptable terms ability pbm business establish maintain contractual relationships network pharmacies acceptable terms as pharmacy retailer compete drugstore chains supermarkets discount retailers independent pharmacies membership clubsinternet companies retail health clinics well mail order pharmacies pbmsin regard many pharmacy benefit plans implemented plan designs mandate provide incentives fill maintenance medications mail order pharmacies to extent trend continues retail pharmacy business could adversely affected although effect would likely mitigated increase mail order business andor increase participation maintenance choice program in addition competitors may offer services pricing terms may willing able offer competition may also come sources future competitors pbm industry include large national pbm companies medco esi well many local regional pbmsin addition several large health insurers managed care plans eg united healthcare cigna pbm capabilities well several national regional companies provide services some competitors may offer services pricing terms may willing able offer in addition competition may also come sources future in medco esi announced plans merge businesses subject various closing conditions regulatory approvals it remains unclear whether merger occur cannot predict impact proposed merger completed competitive landscape table contents reform us health care system congressional efforts reform us health care system finally came fruition passage ppaca bring significant structural changes health insurance system decades while bulk structural changes enacted ppaca implemented key changes individual mandate already challenged judicial legislative levels expected increased government regulation involvement health care while reforms may affect business directly affect coverage plan designs provided many health plan clients as result could indirectly impact many services business practices the company cannot predict effect ppaca changes may retail pharmacy pharmacy services businesses possible legislative market driven changes health care system company cannot anticipate could also occur the failure properly maintain information technology systems information security systems infrastructure support business protect privacy security sensitive customer business information many aspects operations dependent information systems information collected processed stored handled systems throughout operations receive retain transmit certain confidential information including personal information customers clients provide purchase products services enroll programs services register websites interact personnel otherwise communicate us in addition operations depend part secure transmission confidential information public networks our information systems subject damage interruption power outages computer telecommunications failures computer viruses security breaches vandalism catastrophic events human error although developed systems processes designed protect confidential information security breaches compromise information security controls businesses interact results confidential information accessed obtained used unauthorized improper persons could harm reputation expose us regulatory actions claims customers clients financial institutions payment card associations persons could adversely affect business financial position results operations moreover security breach could require expend significant resources related information systems infrastructure could distract management key personnel performing primary operational duties if information systems damaged fail work properly otherwise become unavailable unable successfully complete planned consolidation pbm claims adjudication platforms may incur substantial costs repair replace may experience loss critical information customer disruption interruptions delays ability perform essential functions in addition compliance changes privacy information security laws standards may result considerable expense due increased investment technology development new operational processes table contents risks related compliance broad complex regulatory framework the pbm business retail pharmacy business subject numerous federal state local laws regulations see business government regulation changes regulations may require extensive system operating changes may difficult implement untimely compliance noncompliance applicable laws regulations could adversely affect continued operation business including limited imposition civil criminal penalties suspension disgorgement payments government programs loss required government certifications approvals loss authorizations participate exclusion government reimbursement programs medicare medicaid programs loss licensure the regulations subject include limited laws regulations described government regulation section accounting standards securities laws regulations tax laws regulations laws regulations relating protection environment health safety matters including governing exposure management disposal hazardous materials wastes regulations fda ftc dea consumer product safety commission well state regulatory authorities governing sale advertisement promotion products sell we also subject terms government agreements described government regulation section in regard business financial position results operations could affected existing new government legislative regulatory action including without limitation one following federal state laws regulations governing purchase distribution management dispensing reimbursement prescription drugs related services whether retail mail applicable licensing requirements effect expiration patents covering brand name drugs introduction generic products frequency rate approvals fda new brand named generic drugs counter status brand name drugs fda regulation affecting retail pbm industry rulesand regulations issued pursuant hipaa hitech act federal state laws affecting collection use disclosure transmission health personal information federal laws information privacy precipitated concerns information collection internet state security breach laws state laws limiting use disclosure prescriber information administration medicare partd including legislative changes andor cms rulemaking interpretation government regulation development administration review updating formularies drug lists federal state local waste management laws regulations applicable business including management pharmaceutical wastes photo processing solutions well storage transportation hazardous materials state laws regulations establishing changing prompt payment requirements payments retail pharmacies impact network access legislation including willing provider laws ability manage pharmacy networks managed care reform plan design legislation insurance licensing insurance regulatory requirements applicable offering medicare partd programs services direct regulation pharmacies pbms regulatory quasi regulatory bodies risks related litigation legal proceedings pharmacy services retail pharmacy highly regulated litigious industries our company currently subject various litigation matters legal proceedings as refer item legal proceedings additional information the foregoing comprehensive listing assurance correctly identified appropriately assessed factors affecting business as refer managements discussion analysis financial condition results operations includes cautionary statement concerning forward looking statements end section annual report stockholders year ended december section incorporated reference table contents itemb unresolved staff comments there unresolved sec staff comments item properties we lease stores long term leases vary rental amounts expiration dates renewal options rental provisions for additional information amount rental obligations leases refer note leases annual report stockholders year ended december section incorporated reference herein as december owned approximately retail stores net selling space retail drugstores increased million square feet december nearly one half store base opened significantly remodeled within last five years we eleven distribution centers located alabama california hawaii new york rhode island south carolina tennessee texas lease nine additional facilities located arizona floridaindiana michigan new jersey pennsylvania texas virginia the distribution centers total approximately million square feet december during opened two new distribution centers one chemung county new york one kapolei hawaii as december owned one mail service pharmacy located texas leased three additional mail service pharmacies located floridaillinois pennsylvania we leased call centers located missouri pennsylvania tennessee texas as december also onsite pharmacy stores leased specialty pharmacy stores leased specialty mail order pharmacies one owned we corporate offices located woonsocket rhode island totals approximately square feet during expanded corporate offices state rhode island in addition lease large corporate offices scottsdale arizona northbrookillinois irving texas in connection certain business dispositions completed continue guarantee lease obligations approximately former stores we indemnified guarantee obligations respective purchasers these guarantees generally remain effect initial lease term extension thereof pursuant renewal option provided lease prior time disposition for additional information refer note commitmentsand contingencies annual report stockholders year ended december section incorporated reference herein management believes owned leased facilities suitable adequate meet companys anticipated needs at end existing lease terms management believes leases renewed replaced alternate space table contents the following breakdown state district columbia puerto rico retail stores onsite pharmacy stores specialty pharmacy stores specialty mail order pharmacy locations december retailstores onsitepharmacy stores specialtypharmacy stores specialtymailorder pharmacies total alabama arizona california colorado connecticut delaware district columbia florida georgia hawaii iowa illinois indiana kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania puerto rico rhode island south carolina tennessee texas vermont virginia washington west virginia wisconsin table contents item legal proceedings ilegal proceedings caremark term caremark used herein generally refer one pharmacy benefit management subsidiaries company applicable defendant qui tam lawsuit initially filed relator behalf various state federal government agencies texas federal court the case unsealed may the case seeks monetary damages alleges caremarks processing medicaid certain government claims behalf clients allegedly resulted underpayments clients applicable government agencies one caremarks adjudication platforms violates applicable federal state false claims acts fraud statutes the united states states texas tennessee florida arkansas louisiana california intervened lawsuit tennessee florida withdrew lawsuit august may respectively thereafter company prevailed several motions partial summary judgment following appellate ruling fifth circuit court appeals affirmed part reversed part prior rulings claims asserted case caremark substantially narrowed in april state texas filed purported civil enforcement action caremark injunctive relief damages civil penalties travis county texas alleging caremark violated texas medicaid fraud prevention act state laws based processing texas medicaid claims behalf pbm clients in september company prevailed motion partial summary judgment state texas narrowed remaining claims lawsuit the claims issues raised lawsuit related claims issues pending federal qui tam lawsuit described in december company received document subpoena oig requesting information relating processing medicaid government agency claims different adjudication platform caremark in october october company received civil investigative demands office attorney general state texas requesting respectively information produced oig subpoena information related processing medicaid claims these civil investigative demands state office attorney general state texas investigating allegations currently pending seal relating two caremarks adjudication platforms the company producing documents rolling basis response requests information contained oig subpoena civil investigative demands the company cannot predict certainty timing outcome review information caremark named putative class action lawsuit filed october alabama state court john lauriello purportedly behalf participants settlement various securities class action derivative lawsuits caremark others other defendants include insurance companies provided coverage caremark respect settled lawsuits the lauriello lawsuit seeks approximately billion compensatory damages plus non specified damages based allegations amount insurance coverage available settled lawsuits misrepresented suppressed similar lawsuit filed november frank mcarthur also alabama state court naming defendants caremark several insurance companies attorneys law firms involved settlement this lawsuit stayed later filed class action mcarthur subsequently allowed intervene lauriello action the attorneys law firms named defendants mcarthurs intervention pleadings dismissed case discovery class certification adequacy issues underway various lawsuits filed alleging caremark violated applicable antitrust laws establishing maintaining retail pharmacy networks client health plans in august bellevue drug co robert schreiberinc dba burns pharmacy rehn huerbinger drug co dba parkway drugs together pharmacy freedom fund national community pharmacists association filed putative class action caremark pennsylvania federal court seeking treble damages injunctive relief this case initially sent arbitration based contract terms pharmacies caremarkin october two independent pharmacies north jackson pharmacyinc ccinc dba big discount drugsinc filed putative class action complaint alabama federal court caremark two pbm competitors seeking treble damages injunctive relief the north jackson pharmacy case two caremark entities named defendants transferred illinois federal court case separate caremark entity sent arbitration based contract terms pharmacies caremark the bellevue arbitration stayed parties pending developments north jackson pharmacy court case table contents in august bellevue case north jackson pharmacy case transferred pennsylvania federal court judicial panel multidistrict litigation coordinated consolidated proceedings cases panel including cases pbmscaremark appealed decision vacated order compelling arbitration staying proceedings bellevue case following appeal court appeals reinstated order compelling arbitration bellevue case motions class certification coordinated cases within multidistrict litigation including north jackson pharmacy case remain pending the consolidated action known in re pharmacy benefit managers antitrust litigation in august company notified ftc conducting non public investigation ftca certain companys business practicesin march company learned various state attorneys general offices certain government agencies conducting multi state investigation company regarding issues similar investigated ftcat time states district columbia county los angeles known participating multi state investigation on january ftc accepted public comment subject final approval consent order the proposed consent order would prohibit company misrepresenting price cost medicare partd prescription drugs prices costs associated medicare partd prescription drug plans the proposed order would also require company pay million consumer redress distributed impacted rxamerica medicare partd beneficiaries the proposed order contains allegations antitrust law violations anti competitive behavior related companys business practices products service offerings in addition company received formal letter ftc closing aspects investigation with respect multi state investigation company continues cooperate investigation the company able predict certainty timing outcome multi state investigation however remains confident business practices service offerings designed reducehealth care costs andexpand consumer choiceare conducted compliance antitrust laws in march company received subpoena oig requesting information concerning medicare partd prescription drug plans rxamerica pbm subsidiary longs drug stores corporation acquired company october the company continues respond request information producing responsive documents rolling basis the company cannot predict certainty timing outcome review government information since march company named series putative collective class action lawsuits filed federal courts around country purportedly behalf current former assistant store managers working companys stores various locations outside california the lawsuits allege company failed pay overtime assistant store managers required fair labor standards act flsa certain state statutes the lawsuits also seek relief including liquidated damages punitive damages attorneys fees costs injunctive relief arising state federal claims overtime pay the company aggressively challenged merits lawsuits allegation cases certified class collective actions in light cost uncertainty involved litigation however company reached agreement plaintiffs counsel settle series lawsuits the court preliminarily approved settlement december company anticipates final court approval granted second quarter the company established legal reserves related matters fully cover settlement payments in november securities class action lawsuit filed united states district court district rhode island purportedly behalf purchasers cvs caremark corporation stock may november the lawsuit names company certain officers defendants includes allegations securities fraud relating public disclosures made company concerning pbm business allegations insider trading in addition shareholder derivative lawsuit filed december court directors certain officers company derivative lawsuit lawsuit filed shareholder purporting assert claims behalf corporation directors officers corporation this lawsuit includes allegations among things securities fraud insider trading breach fiduciary duties alleges company damaged purchase stock allegedly inflated prices share repurchase program in january lawsuits transferred united states district court district new hampshire the company believes lawsuits without merit company plans defend vigorously the company received subpoena dated february sec requesting among corporate records information relating public disclosures made company concerning pbm medicare partd businesses information concerning ownership transactions companys securities certain officers company the company received related subpoena dated september sec seeking among things additional information concerning securities transactions certain employees company public disclosures made company the company cooperating requests information providing documents information sec requested table contents in march company received subpoena oig requesting information programs company offered customers remuneration conditioned upon transfer prescriptions drugs medications pharmacies form gift cards cash non prescription merchandise discounts coupons non prescription merchandise the subpoena relates investigation possible false otherwise improper claims payment medicare medicaid programs the company continues respond request information producing responsive documents rolling basis we cannot predict certainty timing outcome reviews government information in january company received subpoena oig requesting information health savings pass program prescription drug discount program uninsured insured individuals connection investigation possible false otherwise improper claims payment involving hhs programs in february company also received civil investigative demand office attorney general state texas requesting copy information produced oig subpoena information related prescription drug claims submitted pharmacies texas medicaid reimbursement the company respond requests information cooperate investigationswe cannot predict certainty timing outcome review applicable government agency requested information the company also party legal proceedings inquiries arising normal course business none expected material company we give assurance however business financial condition results operations materially adversely affected required materially change business practices based ifuture enactment new health care laws regulations iithe interpretation application existing laws regulations including laws regulations described government regulation section may relate business pharmacy services retail pharmacy retail clinic industry health care industry generally iiipending future federal state governmental investigations business pharmacy services retail pharmacy retail clinic industry health care industry generally ivinstitution government enforcement actions us vadverse developments pending qui tam lawsuit us whether sealed unsealed future qui tam lawsuit may filed us viadverse developments pending future legal proceedings us affecting pharmacy services retail pharmacy retail clinic industry health care industry generally iienvironmental matters item sec regulation requires disclosure certain environmental legal proceedings management reasonably believes proceedings involve potential monetary sanctions negotiations remain ongoing state connecticut regarding consent order resolving alleged noncompliance hazardous waste regulations certain companys stores connecticut the company cannot predict ultimate outcome negotiations however management believe outcome material adverse effect company the company also received notices violation information requests governmental authorities california currently working several local governments regarding statewide compliance environmental regulations governing management hazardous waste the resolution issues may require payment civil penalties performance one supplemental environmental projects operational changes within stores california the company cannot predict ultimate outcome negotiations however management believe outcome material adverse effect company item submission matters vote security holders no matters submitted vote security holders three months ended december table contents executive officers registrant executive officers registrant the following sets forth name age biographical information executive officers february in case officers term office extends date board directors meeting following next annual meeting stockholders company previous positions responsibilities held executive officers past five years indicated lisa bisaccia age senior vice president chief human resources officer cvs caremark corporation since january vice president human resources cvs pharmacyinc september december troyen brennan md age executive vice president chief medical officer cvs caremark corporation since november executive vice president chief medical officer aetnainc february november president chief executive officer brigham womens physician hospital organization february also president chief executive officer brigham womens physicians organization february mark cosby age executive vice president cvs caremark corporation president cvspharmacy since september president stores macysinc retail chain april august president macys east april march executive vice president real estate development macys july march laird daniels age senior vice president controller chief accounting officer cvs caremark corporation since january vice president finance retail controller cvs pharmacyinc may december vice president finance corporate budgeting analysis cvs pharmacyinc november april david denton age executive vice president chief financial officer cvs caremark corporation cvs pharmacyinc since january senior vice president controllerchief accounting officer cvs caremark corporation march december senior vice president financial administration cvs caremark corporation cvs pharmacyinc april march senior vice president finance controller pharmacare management servicesinc october april helena foulkes age executive vice president chief health care strategy marketing officer cvs caremark corporation since march executive vice president chief marketing officer cvs caremark corporation january february senior vice president health services cvs caremark corporation may january cvs pharmacyinc october january senior vice president marketing operations services cvs pharmacyinc january october david joyner age executive vice president cvs caremark corporation since march executive vice president sales account services caremark pharmacy services since march per gh lofberg age executive vice president cvs caremark corporation president caremark pharmacy services since january president chief executive officer generation healthinc pharmacogenomics company november december president chief executive officer merck capital ventures llc venture capital investment company focused pharmaceutical industry january july stuart mcguigan age senior vice president chief information officer cvs caremark corporation since january senior vice president chief information officer cvs pharmacyinc since december senior vice president chief information officer liberty mutual group september november also director netscout systemsinc leading provider integrated network application performance management solutions table contents larry merlo age president chief executive officer cvs caremark corporation since march president chief operating officer cvs caremark corporation may march president cvspharmacy january august executive vice president cvs caremark corporation january may executive vice presidentstores cvs corporation april january executive vice presidentstores cvs pharmacyinc march january also director cvs caremark corporation since may jonathan roberts age executive vice president cvs caremark corporation chief operating officer caremark pharmacy services since october executive vice president rx purchasing pricing network relations cvs caremark corporation january october senior vice president chief information officer cvs caremark corporation may january cvs pharmacyinc january january douglas sgarro age executive vice president chief legal officer cvs caremark corporation cvs pharmacyinc since march president cvs realty co real estate development company division cvs pharmacyinc october august andrew sussman md age senior vice president associate chief medical officer cvs caremark corporation since march president minuteclinic llc companys retail based health clinic subsidiary since september executive vice president chief operating officer university massachusetts memorial medical center major teaching affiliate umass medical school may august table contents partii item market registrants common equity related stockholder matters issuer purchases equity securities our common stock listed new york stock exchange symbol cvs the table sets forth high low sale prices common stock new york stock exchange composite tape quarterly cash dividends declared per share common stock periods indicated firstquarter secondquarter thirdquarter fourthquarter fiscalyear high low cash dividends per common share high low cash dividends per common share cvs caremark paid cash dividends every quarter since becoming public company future dividend payments depend companys earnings capital requirements financial condition factors considered relevant companys board directors as february registered shareholders according records maintained transfer agent on august board directors authorized share repurchase program billion outstanding common stock repurchase program the share repurchase authorization repurchase program effective immediately permits us effect repurchases time time combination open market repurchases privately negotiated transactions accelerated share repurchase transactions andor derivative transactions the share repurchase program may modified extended terminated board directors time pursuant authorization repurchase program august company entered billion fixed dollar accelerated share repurchase asr agreement barclays bank plc barclays the asr agreement contained provisions establish minimum maximum number shares repurchased term pursuant asr agreement august company paid billion barclays exchange barclays delivering million shares common stock company on september upon establishment minimum number shares repurchased barclays delivered additional million shares common stock company the company received additional million shares common stock december due fluctuation market price common stock term asr agreement concluded december the total million shares common stock delivered company barclays term asr agreement placed treasury stock on june companys board directors authorized share repurchase program billion outstanding common stock repurchase program during year ended december company repurchased aggregate million shares common stock approximately billion completing repurchase program fiscalperiod totalnumber ofshares purchased average pricepaidper share totalnumberofshares purchasedaspartof publiclyannounced plansorprograms approximatedollar valueofsharesthat mayyetbe purchasedunderthe plansorprograms october october november november december december table contents item selected financial data the selected consolidated financial data cvs caremark corporation periods indicated five year period ended december derived consolidated financial statements cvs caremark corporation the selected consolidated financial data read conjunction consolidated financial statements audit reports ernst young llp incorporated elsewhere herein inmillionsexceptpershareamounts statement operations data net revenues gross profit operating expenses operating profit interest expense net income tax provision income continuing operations income loss discontinued operations net tax net income net loss attributable noncontrolling interest preference dividends net income tax benefit net income attributable cvs caremark per common share data basic earnings per common share income continuing operations attributable cvs caremark loss discontinued operations attributable cvs caremark net income attributable cvs caremark diluted earnings per common share income continuing operations attributable cvs caremark loss discontinued operations attributable cvs caremark net income attributable cvs caremark cash dividends per common share balance sheet data total assets long term debt total shareholders equity number stores end year on december board directors approved change fiscal year end saturday nearest december year december year better reflect position health care rather retail industry the fiscal year change effective beginning fourth quarter fiscal as review operating performance please consider fiscal include days fiscal includes days fiscal include days effective march caremark rxinc merged newly formed subsidiary cvs corporation caremark rx llc continuing surviving entity caremark merger following caremark merger name company changed cvs caremark corporation by virtue caremark merger issued outstanding share caremark common stock par value per share converted right receive shares cvs caremarks common stock par value per share cash paid lieu fractional shares income tax provision includes effect following iin recognition million previously unrecognized tax benefits including interest relating expiration various statutes limitation settlements tax authorities iiin recognition million previously unrecognized tax benefits including interest relating expiration various statutes limitation settlements tax authorities as discussed note consolidated financial statements results theracom business presented discontinued operations excluded continuing operations periods presented in connection certain business dispositions completed company retained guarantees store lease obligations number former subsidiaries including linens things filed bankruptcy the companys income loss discontinued operations includes lease related costs company believes likely required satisfy pursuant linens things lease guarantees table contents below summary results discontinued operations fiscalyear inmillions income operations theracom gain disposal theracom loss disposal linens things income tax benefit provision income loss discontinued operations net tax represents minority shareholders portion net loss majority owned subsidiary generation healthinc acquired fourth quarter item managements discussion analysis financial condition results operations we refer managements discussion analysis financial condition results operations includes cautionary statement concerning forward looking statements end section annual report stockholders year ended december section incorporated reference herein itema quantitative qualitative disclosures market risk as december company derivative financial instruments derivative commodity instruments place believes exposure market risk associated financial instruments principally interest rate risk inherent debt portfolio material item financial statements supplementary data we refer consolidated statements income consolidated balance sheets consolidated statements shareholders equity consolidated statements cash flows notes consolidated financial statements report independent registered public accounting firm annual report stockholders fiscal year ended december sections incorporated reference herein item changes disagreements accountants accounting financial disclosure none itema controls procedures evaluation disclosure controls procedures the companys chief executive officer chief financial officer evaluating effectiveness design operation companys disclosure controls procedures defined exchange act rulesa fand december concluded date companys disclosure controls procedures adequate effective designed ensure material information relating company subsidiaries would made known officers timely basis internal control financial reporting we refer managements report internal control over financial reporting report independent registered public accounting firm annual report stockholders fiscal year ended december incorporated reference herein managements report registrants internal control financial reporting independent registered public accounting firms report respect effectiveness internal control financial reporting changes internal control financial reporting there changes internal controls financial reporting identified connection evaluation required paragraph dof rulea ruled occurred fourth quarter ended december materially affected reasonably likely materially affect internal control financial reporting itemb other information no events occurred fourth quarter would require disclosure item table contents partiii item directors executive officers registrant we refer proxy statement annual meeting stockholders captions committees board code conduct director nominations audit committee report biographies board nominees sectionabeneficial ownership reporting compliance sections incorporated reference herein biographical information executive officers contained parti annual report form item executive compensation we refer proxy statement annual meeting stockholders captions executive compensation related matters including compensation discussion analysis management planning development committee report sections incorporated reference herein item security ownership certain beneficial owners management related stockholder matters we refer proxy statement annual meeting stockholders captions share ownership directors certain executive officers share ownership principal stockholders sections incorporated reference herein information concerning security ownership certain beneficial owners management related stockholder matters the following table summarizes information companys common stock may issued upon exercise options warrants rights equity compensation plans december numberof securitiestobe issuedupon exerciseof outstanding optionswarrants andrights weighted averageexercise priceof outstanding optionswarrants andrights numberofsecurities remainingavailablefor futureissuanceunder equitycompensation plansexcluding securitiesreflectedin firstcolumn equity compensation plans approved stockholders equity compensation plans approved stockholders total shares thousands the number shares available delivery incentive compensation plan icp subject adjustment event shares subject awards either icp predecessor plan cancelled forfeited event shares shall available grants awards item certain relationships related transactions director independence we refer proxy statement annual meeting stockholders caption independence determinations directors certain transactions directors officers sections incorporated reference herein item principal accountant fees services we refer proxy statement annual meeting stockholders caption item ratification appointment independent registered public accounting firm section incorporated reference herein table contents partiv item exhibits financial statement schedules documents filed part report financial statements the following financial statements incorporated reference annual report stockholders fiscal year ended december provided item hereof consolidated statements income years ended december consolidated balance sheets december consolidated statements cash flows years ended december consolidated statements shareholders equity years ended december notes consolidated financial statements report independent registered public accounting firm financial statement schedules all financial statement schedules omitted applicable required instructions information included consolidated financial statements related notes exhibits exhibits marked asterisk hereby incorporated reference exhibits appendices previously filed registrant indicated brackets following description exhibit exhibit description agreement plan merger dated november among registrant caremark rxinc twain mergersub corp incorporated reference exhibit registrants registration statement no forms filed december amendment no dated january agreement plan merger dated november among registrant caremark rxinc twain merger sub corp incorporated reference exhibit registrants registration statement no forms filed january waiver agreement dated january registrant caremark rxinc respect agreement plan merger dated november registrant caremark rxinc incorporated reference exhibit registrants registration statement no forms filed january amendment waiver agreement dated february registrant caremark rxinc incorporated reference exhibit registrants current report form dated february commission file no amendment waiver agreement dated march registrant caremark rxinc incorporated reference exhibit registrants current report form dated march commission file no agreement plan merger dated august among registrant longs drug stores corporation blue mergersub corp incorporated reference exhibit registrants current report form dated august commission file no amended restated certificate incorporation registrant incorporated reference exhibit cvs corporations annual report form fiscal year ended december commission file no table contents certificate amendment amended restated certificate incorporation effective may incorporated reference exhibita registrants registration statement no forms dated may certificate amendment amended restated certificate incorporation incorporated reference exhibit registrants current report form dated march commission file no certificate merger dated may incorporated reference exhibitc registrants quarterly report form dated november commission file no certificate amendment amended restated certificate incorporation incorporated reference exhibit registrants current report form dated may commission file no by laws registrant amended restated incorporated reference exhibit registrants current report form dated may commission file no pursuant regulation kitem biiia instrument defines rights holders long term debt registrant subsidiaries filed report the registrant hereby agrees furnish copy instrument securities exchange commission upon request specimen common stock certificate incorporated reference exhibit registration statement registrant form dated november commission file no specimen first supplemental indenture registrant the bank new york trust company national banking association incorporated reference exhibit registrants current report form dated may commission file no specimen ecaps sm incorporated reference exhibit registrants current report form dated may commission file no stock purchase agreement dated october the tjx companiesinc melville corporation amended november incorporated reference exhibits melvilles current report form dated december commission file no stock purchase agreement dated march melville corporation consolidated stores corporation amended may incorporated reference exhibits melvilles current report form dated may commission file no distribution agreement dated september among melville corporation footstarinc footstar centerinc incorporated reference exhibit melvilles current report form dated october commission file no tax disaffiliation agreement dated september among melville corporation footstarinc certain subsidiaries named therein incorporated reference exhibit melvilles current report form dated october commission file no stockholder agreement dated december registrant nashua hollis cvsinc linens thingsinc incorporated reference exhibitito registrants annual report form fiscal year ended december commission file no table contents tax disaffiliation agreement dated december registrant linens thingsinc certain respective affiliates incorporated reference exhibitito registrants annual report form fiscal year ended december commission file no supplemental retirement plan select senior management cvs caremark corporation amended restated december incorporated reference exhibit registrants quarterly report form quarter ended june commission file no cvs corporation directors stock plan amended restated november incorporated reference exhibit registrants annual report form fiscal year ended december commission file no cvs caremark deferred stock compensation plan amended restated incorporated reference exhibit registrants quarterly report form quarter ended june commission file no incentive compensation plan amended december incorporated reference exhibit registrants quarterly report form quarter ended june commission file no incentive plan amended restated december incorporated reference exhibit registrants quarterly report form quarter ended june commission file no caremark rxinc incentive stock plan incorporated reference exhibit registrants registration statement no forms filed march caremark rxinc deferred compensation plan effective april amended restated december incorporated reference exhibit registrants quarterly report form quarter ended june commission file no cvs caremark deferred compensation plan amended restated december incorporated reference exhibit registrants quarterly report form quarter ended june commission file no cvs partnership equity program incorporated reference exhibit registrants quarterly report form quarter ended june commission file no employee stock purchase plan incorporated reference exhibitd registrants definitive proxy statement filed april commission file no retention agreement dated august registrant registrants former chief executive officer incorporated reference exhibit registrants quarterly report form quarterly period ended october commission file no formof restricted stock unit agreement registrant registrants former chief executive officer incorporated reference exhibit registrants quarterly report form quarterly period ended october commission file no table contents amended restated employment agreement dated december registrant registrants former chairman board chief executive officer incorporated reference exhibit registrants annual report form fiscal year ended december commission file no amended restated employment agreement dated december registrant registrants president chief executive officer incorporated reference exhibit registrants annual report form fiscal year ended december commission file no amended restated employment agreement dated december registrant registrants executive vice president chief legal officer incorporated reference exhibit registrants annual report form fiscal year ended december commission file no five year credit agreement dated march among registrant lenders party thereto lehman commercial paper inc wachovia bank na co syndication agents morgan stanley senior fundinginc documentation agent bank new york administrative agent incorporated reference exhibit registrants current report form dated march commission file no global amendment dated march ifive year credit agreement dated june iifive year credit agreement dated june iiifive year credit agreement dated may ivfive year credit agreement dated march day credit agreement dated march incorporated reference exhibit registrants current report form dated march commission file no universal definition document dated december incorporated reference exhibit registrants quarterly report form quarter ended june commission file no formof non qualified stock option agreements registrant selected employees registrant incorporated reference exhibit registrants annual report form fiscal year ended december commission file no formof restricted stock unit agreement registrant selected employees registrant incorporated reference exhibit registrants annual report form fiscal year ended december commission file no cvs caremark long term incentive plan incorporated reference exhibit registrants annual report form fiscal year ended december commission file no table contents partnership equity program purchased share matching restricted stock unit stock option agreement registrant selected employees registrant incorporated reference exhibit registrants annual report form fiscal year ended december commission file no incentive compensation plan incorporated reference exhibit registrants current report form dated may commission file no three year credit agreement dated may among registrant lenders party hereto barclays capital jp morgan chase bank na co syndication agents bank america na wells fargo bank na co documentation agents bank new york mellon administrative agent incorporated reference exhibit registrants quarterly report form fiscal quarter ended june commission file no employment agreement registrant registrants executive vice president president caremark pharmacy services effective january incorporated reference exhibit registrants annual report form fiscal year ended december commission file no change control agreement registrant registrants executive vice president president caremark pharmacy services effective january incorporated reference exhibit registrants annual report form fiscal year ended december commission file no long term incentive plan president pharmacy benefit management incorporated reference exhibit registrants annual report form fiscal year ended december commission file no return net assets long term incentive plan incorporated reference exhibit registrants annual report form fiscal year ended december commission file no change control agreement dated december registrant registrants executive vice president chief financial officer incorporated reference exhibit registrants annual report form fiscal year ended december commission file no letter agreement dated january registrant registrants former chairman chief executive officer incorporated reference exhibit registrants quarterly report form fiscal quarter ended march commission file no four year credit agreement dated may among registrant lenders party thereto barclays capital jp morgan chase bank na co syndication agents bank america na wells fargo bank na co documentation agents bank new york mellon administrative agent incorporated reference exhibit registrants quarterly report form fiscal quarter ended june commission file no letter agreement dated january registrant registrants former chairman chief executive officer incorporated reference exhibit registrants quarterly report form fiscal quarter ended march commission file no executive severance policy effective march management incentive plan letter agreement dated august registrant registrants executive vice president president cvspharmacy change control agreement dated september registrant registrants executive vice president president cvspharmacy amendment no dated november five year credit agreement dated march among registrant lenders party thereto co syndication agents documentation agent named therein the bank new york mellon administrative agent amendment no dated november three year credit agreement dated may among registrant lenders party thereto co syndication agents co documentation agents table contents named therein the bank new york mellon administrative agent amendment no dated november credit agreement dated may among registrant lenders party thereto co syndication agents co documentation agents named therein the bank new york mellon administrative agent formof performance based restricted stock unit agreement formof partnership equity plan purchased matching restricted stock unit stock option agreement portions annual report stockholders cvs caremark corporation specifically designated form incorporated reference subsidiaries registrant consent ernst young llp certification chief executive officer pursuant section sarbanes oxley act certification chief financial officer pursuant section sarbanes oxley act certification chief executive officer pursuant section sarbanes oxley act certification chief financial officer pursuant section sarbanes oxley act the following materials cvs caremark corporation annual report form year ended december formatted extensible business reporting language xbrl ithe consolidated statements income iithe consolidated balance sheets iiithe consolidated statements cash flows ivrelated notes table contents signatures pursuant requirements section dof securities exchange act registrant duly caused annual report form signed behalf undersigned thereunto duly authorized cvs caremark corporation date february by sdavid denton david denton executive vice president chief financial officer pursuant requirements securities exchange act report signed following persons behalf registrant capacities dates indicated signature titles date sedwin banks director february edwin banks sc david brown ii director february cdavid brown ii slaird daniels senior vice president february laird daniels finance controller principal accounting officer sdavid denton executive vice president chief february david denton financial officer principal financial officer sdavid dorman chairman board director february david dorman sanne finucane director february anne finucane skristengibneywilliams director february kristen gibney williams smarian heard director february marian heard slarry merlo president chief executive february larry merlo officer principal executive officer director table contents signature titles date sjean pierre millon director february jean pierre millon sterrence murray director february terrence murray sca lance piccolo director february ca lance piccolo srichard swift director february richard swift stony white director february tony white